首页> 中文学位 >Changes in serum level of Ghrelin,Tumor Necrosis Factor-α&Interleukin-6in Children with Conegenital Heart Disease
【6h】

Changes in serum level of Ghrelin,Tumor Necrosis Factor-α&Interleukin-6in Children with Conegenital Heart Disease

代理获取

目录

声明

TABLE OF CONTENTS

ABBREVIATION

ABSTRACT

1.INTRODUCTION

Background of the study

Summary

Purpose of study

2.MATERIAL AND METHODS

3.RESULTS

4.DISCUSSION

5.CONCLUSION

REFERENCES

ACKNOWLEDGEMENT

PUBLISHED ARTICLES

展开▼

摘要

Objective: To investigate the changes in serum levels of ghrelin, tumor necrosis factor-α and interleukin-6 in Children with Congenital Heart Disease (CHD) at pre and post percutaneous closure of the defects.
  Method & Materials: We measured the serum levels of gherlin, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) by enzyme linked immunosorbent assays (ELISA) in 67 patients with CHD and in 20 control subjects; and compared these markers of inflammatory reaction between groups ofpre-closure (37 patients) and at the end of 5 minutes (37 patients),1 month (22 patients) and 3 month (8 patients) post percutaneous closure of the defects.
  Results: Our results showed that the patients with CHD had significantly higher serum level of Ghrelin, TNF-α and IL-6 in comparison of the controls but gradually return towards the baseline levels at the end of 3 months after closure of the defects.
  Conclusion: The inflammatory reaction is activated in pre-closure and self-limited post-closure in children with CHD.Percutaneous closure could improve the inflammatory process, which is safe and effective in children with CHD.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号